NCT01315457已完成不适用
Asian Multinational Retrospective Analysis for Infectious Complications in Patients Treated With Alemtuzumab
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 182
- 试验地点
- 5
- 主要终点
- Infectious event
研究概览
简要总结
The aim of this study is to propose infection prophylaxis from Asian multinational retrospective analysis of infectious complications in patients who were treated with alemtuzumab
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 15 Years 至 90 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients received alemtuzumab as a treatment for hematologic malignancy ex. non-Hodgkin lymphoma Acute myeloid leukemia Aplastic anemia
排除标准
- •Patients did not receive alemtuzumab
结局指标
主要结局
Infectious event
时间窗: one year
Any infectious complication occurred within one year after the use of alemtuzumab
次要结局
未报告次要终点
研究者
Won Seog Kim
Professor
Samsung Medical Center
研究点 (5)
Loading locations...
相似试验
已完成
不适用
An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East CountriesDiabetesDiabetes Mellitus, Type 2NCT00842192Novo Nordisk A/S2,155
已完成
不适用
Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 DiabetesDelivery SystemsDiabetesDiabetes Mellitus, Type 2NCT00715663Novo Nordisk A/S1,584
已完成
不适用
Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical PracticeDiabetes Mellitus, Type 2DiabetesNCT01492166Novo Nordisk A/S1,935
已完成
不适用
To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in JapanCongenital Bleeding DisorderHaemophilia ANCT02207218Novo Nordisk A/S40
已完成
不适用
A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment of Congenital FXIII Deficiency in JapanCongenital Bleeding DisorderCongenital FXIII DeficiencyNCT02670213Novo Nordisk A/S8